Subscribe To
SYFOVRE® (pegcetacoplan injection) Continued to Demonstrate Increasing Treatment Effects Over 3 Years in Patients with Geographic Atrophy (GA)
SYFOVRE reduced nonsubfoveal GA lesion growth by over 40% (monthly) in Year 3 compared to projected sham in the GALE extension study Well-demonstrated safety profile consistent with previously reported clinical data Approximately 92% of patients enrolled in GALE completed the first year of the study, demonstrating robust long-term compliance Data were presented during an oral […] The post SYFOVRE® (pegcetacoplan injection) Continued to Demonstrate Increasing Treatment Effects Over 3 Years in Pat...
Read More
Posted: Nov 4 2023, 17:37
Author Name: forextv
Views: 011838